Quince Therapeutics files 8-K on director changes
Quince Therapeutics said several directors resigned from its board and named four new directors effective Oct. 8, 2026. The filing also disclosed compensation terms for Keith R. Fandrick.
Quince Therapeutics said several directors resigned from its board and named four new directors effective Oct. 8, 2026. The filing also disclosed compensation terms for Keith R. Fandrick.